March 5, 2026

On February 25, 2026, the Kansas State Board of Healing Arts and Board of Pharmacy issued a significant new joint statement addressing the rapidly growing IV hydration and medical spa (medspa) industry. The Kansas State Board of Healing Arts and the Kansas Board of Pharmacy released this advisory in response to increasing complaints involving IV therapy services, including allegations of “out‑of‑scope practice, delegation of medical treatments to unqualified individuals, unauthorized compounding… and the unlicensed practice of the healing arts and pharmacy.”

Although the statement is not a legally binding regulation, it signals the Boards’ enforcement priorities and outlines expectations for any business offering IV hydration or vitamin infusion services in Kansas. Kansas medspas and clinics offering IV hydration services should review the statement and consider conducting an internal audit to identify and correct any practices that are not in line with current laws and regulations.

Highlights of the Boards’ Joint Statement

1. IV Therapy Is the Practice of the Healing Arts

The Boards emphasize that any intravenous administration of drugs—including saline, vitamins, minerals, amino acids, and other additives— “indisputably constitutes the practice of healing arts.”

2. Strict Limits on Who May Administer IV Therapy

The statement makes clear that only individuals with prescriptive authority may administer IV products. This is a significant tightening of expectations for many IV hydration clinics.

3. Compounding Rules Apply to IV “Cocktails”

The Boards take the position that mixing additives into saline constitutes the act of drug compounding. This restriction implicates medspas that prepare IV bags (e.g., combining vitamins with saline bags) on‑site without a pharmacist or physician performing or supervising the compounding process.

4. Pre‑Set Menus Are Not Valid Prescriptions

Many IV hydration businesses rely on pre‑approved “menus” of IV cocktails. The Boards warn that they view this practice as non‑compliant. As stated, “A patient may not self‑prescribe IV products… Prescriber involvement cannot be obviated by letting the patient direct their own care.”

Seigfreid Bingham’s health care lawyers will continue to monitor developments in this area and stand ready to assist clients with advice on the current medspa regulatory landscape.  This article is general in nature and does not constitute legal advice. If you have legal questions, please consult either of the authors: Emily Crane (816.265.4175; ecrane@sb-kc.com), Colby Stone (816.265.4162; cstone@sb-kc.com), or your regular contact at Seigfreid Bingham at 816.421.4460.